Mankind Pharma Ltd. is poised for growth, says Jefferies. (Image source: Company website) Show Quick Read Summary is AI Generated. Newsroom Reviewed

Mankind Pharma Ltd. remains one of Jefferies preferred picks despite the September quarter setback. According to the brokerage the company is among the best-in-class franchises currently navigating a temporary rough patch.

However, Jefferies has trimmed the target price of Mankind Pharma to Rs 3,000 from Rs 3,100, citing a slower-than-expected recovery in its reorganisation efforts.

The brokerage said the company’s September quarter results were broadly in line with subdued expectations, with operating performance steady but margins likely to stay at the lower end of guidance in the near term.

Jefferies believes that Mankind is poised

See Full Page